Provided by Tiger Trade Technology Pte. Ltd.

CALIDI BIOTHERAPEUTICS INC

0.8620
+0.01992.36%
Post-market: 0.86200.00000.00%19:31 EST
Volume:34.09K
Turnover:30.18K
Market Cap:6.18M
PE:-0.10
High:0.9015
Open:0.8753
Low:0.8620
Close:0.8421
52wk High:19.20
52wk Low:0.8373
Shares:7.17M
Float Shares:3.84M
Volume Ratio:0.33
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.0217
EPS(LYR):-35.7001
ROE:--
ROA:-119.65%
PB:0.89
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
CALIDI BIOTHERAPEUTICS INC
Exchange:
AMEX
Establishment Date:
2014
Employees:
28
Office Location:
4475 Executive Drive,Suite 200,San Diego,California,United States
Zip Code:
92121
Fax:
858 794 9605
Introduction:
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California.

Directors

Name
Position
Eric Poma
Chief Executive Officer and Director
James Schoeneck
Chairman of the Board and Director
Alan Stewart
Director
Allan Camaisa
Director
George Peoples
Director
Scott Leftwich
Director

Shareholders

Name
Position
Eric Poma
Chief Executive Officer and Director
Andrew Jackson
Chief Financial Officer and Corporate Secretary